Union: Sanofi poised for restructuring

Sanofi-Aventis is prepping for a "major restructuring" of some of its business, trade union officials told Reuters. The French drugmaker is expected to release more details at another union meeting next week. Company officials declined to comment. Report

Suggested Articles

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.